Global Hip Replacement Market Size By Type (Total Hip Replacement Implant, Partial Hip Replacement Implant), By Application (Hospitals, Orthopedics Clinics), By Region, And Segment Forecasts, 2023 to...

The Global Hip Replacement Market was valued at USD 8.9 billion in 2023 and is projected to reach USD 14.6 billion by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. The market is primarily driven by the rising prevalence of osteoarthritis, increasing aging population, and advancements in hip implant technologies. Hip replacement procedures have become more efficient and less invasive due to innovation in surgical techniques, enhancing patient recovery and satisfaction.

Drivers:

1. Rising Geriatric Population and Prevalence of Joint Disorders:

With the global population aging rapidly, the incidence of joint-related conditions like osteoarthritis and rheumatoid arthritis is rising. This demographic trend is a significant contributor to the growth of the hip replacement market.

2. Technological Advancements in Hip Implants and Surgical Techniques:

Modern hip implants made from biocompatible materials such as titanium and ceramic have improved the durability and performance of hip replacement procedures. Innovations such as robotic-assisted surgery and 3D-printed implants are enhancing surgical accuracy and patient outcomes.

3. Increased Awareness and Healthcare Access:

Growing patient awareness and the availability of reimbursement policies in developed nations are increasing the number of elective hip replacement surgeries, further fueling market expansion.

Restraints:

1. High Cost of Hip Replacement Surgery:

The high cost associated with surgical procedures, implants, and post-operative care can be a deterrent, especially in low- and middle-income regions lacking sufficient insurance coverage.

2. Risk of Postoperative Complications and Revision Surgeries:

Despite advances in technology, the risk of complications such as infections, implant loosening, or dislocation remains a concern, which may impact patient decision-making and market growth.

Opportunity:

1. Emerging Markets and Minimally Invasive Procedures:

Regions like Asia-Pacific and Latin America present strong growth opportunities due to rising healthcare investments and increasing demand for minimally invasive surgeries, which offer shorter hospital stays and faster recovery times.

2. Growth in Outpatient Surgical Centers:

The expansion of ambulatory surgical centers equipped to perform hip replacement surgeries is making these procedures more accessible and cost-effective, particularly in urban regions.

Market by System Type Insights:

Based on implant types, the Total Hip Replacement segment dominated the market in 2023. This segment includes cemented, cementless, and hybrid systems, with cementless implants experiencing faster adoption due to better long-term fixation. The Partial Hip Replacement segment is expected to see steady growth, particularly among younger patients or those with hip fractures.

Market by End-use Insights:

In 2023, Hospitals accounted for the largest market share due to the availability of skilled orthopedic surgeons, advanced infrastructure, and comprehensive care facilities. The Ambulatory Surgical Centers (ASCs) segment is projected to grow rapidly due to their cost-efficiency, shorter wait times, and increasing adoption of outpatient joint replacement procedures.

Market by Regional Insights:

North America held the largest share of the global hip replacement market in 2023, driven by an aging population, high healthcare spending, and widespread adoption of advanced surgical techniques. Europe followed closely, supported by robust reimbursement systems. Asia-Pacific is expected to be the fastest-growing region, owing to increasing healthcare investments, expanding medical tourism, and rising demand for orthopedic procedures.

Competitive Scenario:

Key players in the market include Zimmer Biomet Holdings, Inc., Stryker Corporation, Johnson & Johnson (DePuy Synthes), Smith & Nephew plc, B. Braun Melsungen AG, DJO Global, Inc., Exactech, Inc., Conformis, Inc., MicroPort Scientific Corporation, and Corin Group. These companies focus on product innovation, strategic acquisitions, and expanding their presence in emerging markets to strengthen their competitive position.

Recent Developments:

In 2023, Zimmer Biomet introduced a new AI-enabled hip implant system designed to improve joint alignment and reduce revision rates.

Stryker Corporation announced the expansion of its robotic surgery platform for hip replacements in key European markets in 2024.

In 2025, Smith & Nephew launched a patient-specific planning software integrated with its minimally invasive hip surgery solutions.

Scope of Work – Global Hip Replacement Market

Report Metric Details

Market Size (2023) USD 8.9 billion

Projected Market Size (2031) USD 14.6 billion

CAGR (2023–2031) 6.5%

Key Segments System Type (Total, Partial, Revision), End-use (Hospitals, ASCs)

Growth Drivers Aging population, Technological advancements, Healthcare accessibility

Opportunities Emerging markets, Outpatient surgery growth

Key Market Developments:

Zimmer Biomet launched AI-integrated implants for enhanced surgical precision (2023).

Stryker Corporation expanded robotic-assisted hip surgery in Europe (2024).

Smith & Nephew introduced patient-specific surgical planning software (2025).

FAQs:

What is the current market size of the Global Hip Replacement Market?

The market was valued at USD 8.9 billion in 2023.

What is the major growth driver of the Global Hip Replacement Market?

The rising geriatric population and advancements in implant technology.

Which is the largest region during the forecast period in the Global Hip Replacement Market?

North America is projected to remain the leading region.

Which segment accounted for the largest market share in the Global Hip Replacement Market?

The Total Hip Replacement segment held the largest share in 2023.

Who are the key market players in the Global Hip Replacement Market?

Zimmer Biomet, Stryker, Johnson & Johnson (DePuy Synthes), Smith & Nephew, B. Braun, and others.